Endoscopy 2021; 53(S 01): S122
DOI: 10.1055/s-0041-1724577
Abstracts | ESGE Days
ESGE Days 2021 Digital poster exhibition

Anxiety and Cancerophobia in Patients With Small Gastrointestinal Subepithelial Lesions and Tumours: Baseline Results of a Prospective Study (QUALI-BANDING-SET)

F Bas-Cutrina
1   Endoscopy Unit, Digestive Diseases Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
C Loras
2   Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Catalonia, Spain
,
ME García-Ibáñez
1   Endoscopy Unit, Digestive Diseases Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
X Andujar
2   Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Catalonia, Spain
,
A Casellas-Grau
3   Pysichoncology Unit, Institut Català d’Oncologia (ICO) L’Hospitalet, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
FL Gil
3   Pysichoncology Unit, Institut Català d’Oncologia (ICO) L’Hospitalet, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
C Tebé
4   Bioestatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
M Galán
5   Medical Oncology Department, Institut Català d’Oncologia (ICO) L’Hospitalet, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
F Fernández-Aranda
6   Eating Disorders Unit, Department of Psychiatry, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
S Videla
7   Clinical Research Support Unit, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
,
JB Gornals
1   Endoscopy Unit, Digestive Diseases Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Catalonia, Spain
› Author Affiliations
 

Aims Small subepithelial lesions (SEL) or subepithelial tumours (SET) confirmed once characterized by endoscopic ultrasound (EUS), could generate anxiety and fear of cancer. Main aim: to assess the anxiety burden and cancerophobia in patients with small-sized SELs diagnosis or SETs under EUS surveillance. Secondary aims: to evaluate possible factors or patients’ characteristics influencing on anxiety or fear of cancer degree.

Methods Observational prospective study. Consecutive inclusion of all patients with a small-sized SEL diagnosis (requiring an EUS performance), or patients with a previously catalogued SET under echoendoscopy surveillance. Evaluation of the anxiety-distress degree and fear of cancer using two specific designed and validated instruments-questionnaires: Hospital Anxiety and Depression Scale (HADS), anxiety and depression subscales [0-7 points=normal; 8-10=borderline; 11-21=pathologic], and global-distress scale [0-10 points=normal; 11-17=borderline; 18-42=pathologic]; and Cancer Worry Scale (CWS) [6-10 points=low; 11-15=moderate; 16-20=high; 21-24=very high]. ClinicalTrials.gov register: NCT04316000.

Results Two participating centres, 40 patients (inclusion period: September 2019 - February 2020). Mean HADS-anxiety: 7.2 (+/- 4.3) [= borderline anxiety]; HADS-distress: 11.4 (+/- 7.7) [= borderline distress]; CWS: 11.0 (+/- 4.1) [= moderate concern]. HADS-anxiety and CWS correlation coefficient: 0.75. Belief on probability of having GI cancer now: 20.7 % (+/- 23.6); belief on probability of getting GI cancer in 10 years: 28.6 % (+/- 24.3). Impact on quality of life: Yes 40 % (16/40). Female sex (n-26) vs. male (n-14) subanalysis: HADS-anxiety 8.0 vs. 5.9; HADS-distress 12.7 vs. 9.0; CWS 11.5 vs. 9.9. Family history of cancer YES (n-29) vs. NO (n-11) subanalysis: HADS-anxiety 8.1 vs. 5.0; HADS-distress 12.7 vs. 8.0; CWS 11.7 vs. 9.1.

Tab.1

HADS

anxiety

HADS

distress

Cancer Worry Scale

(CWS)

YES

Impact on quality of life

Female sex (n-26)

8.0

12.7

11.5

53.9 % (n-14)

Male sex (n-14)

5.9

9.0

9.9

14.3 % (n-2)

YES family history of cancer (n-29)

8.1

12.7

11.7

48.3 % (n-14)

NO family history of cancer (n-11)

5.0

8.0

9.1

18.2 % (n-2)

Conclusions Patients with SEL diagnosis or SET under EUS surveillance present a moderate anxiety-distress degree and a moderate concern about having cancer, partially affecting their quality of life. Family history of cancer and female gender are factors that can increase anxiety and cancerophobia degree.

Citation: Bas-Cutrina F, Loras C, García-Ibáñez ME et al. eP78 ANXIETY AND CANCEROPHOBIA IN PATIENTS WITH SMALL GASTROINTESTINAL SUBEPITHELIAL LESIONS AND TUMOURS: BASELINE RESULTS OF A PROSPECTIVE STUDY (QUALI-BANDING-SET). Endoscopy 2021; 53: S122.



Publication History

Article published online:
19 March 2021

© 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany